home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

287 rows where filing_period = "second_quarter", filing_year = 2019 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, received_date (date)

issue_code 1

  • MED · 287 ✖

filing_year 1

  • 2019 · 287 ✖

filing_period 1

  • second_quarter · 287 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2297602 ACT FOR NIH cd54f05b-ba05-491e-99c3-97957ad10461 2T ACT FOR NIH 401103441 ACT FOR NIH 2019 second_quarter MED NIH Appropriations HOUSE OF REPRESENTATIVES,SENATE     0 1 2019-05-31T11:42:18.147000-04:00
2298247 THE CONSILIO GROUP e3f587e9-f36d-4a78-8359-44ac5cf49721 Q2 THE CONSILIO GROUP 400374717 MADEN TECH CONSULTING, INC. 2019 second_quarter MED Infrastructure rebuilding. Federal Emergency Management Agency (FEMA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2019-06-28T12:14:37.213000-04:00
2298335 AUBURN HEALTH STRATEGIES, LLC 819a5272-7215-43cf-bce4-069a7f328743 Q2 AUBURN HEALTH STRATEGIES, LLC 292697 API GROUP (FORMERLY KNOWN AS API FOOD QUALITY INC ) 2019 second_quarter MED quality of laboratory testing Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-07-01T09:10:04.787000-04:00
2298340 AUBURN HEALTH STRATEGIES, LLC 81a98e17-518f-4bea-9ffe-d921dc0e6e6d Q2 AUBURN HEALTH STRATEGIES, LLC 292697 NEUROTECH, LLC 2019 second_quarter MED EEG monitoring HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-07-01T09:15:07.117000-04:00
2298345 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) eacf9798-8a62-4d2c-9a39-57085ddf0a8a Q2 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 PPLA 2019 second_quarter MED Pharmaceutical labeling Food & Drug Administration (FDA) 18700   0 0 2019-07-01T09:23:10.647000-04:00
2298346 AUBURN HEALTH STRATEGIES, LLC f69dd1d6-6334-42c9-bbf2-b5005580aee1 2T AUBURN HEALTH STRATEGIES, LLC 292697 API GROUP (FORMERLY KNOWN AS API FOOD QUALITY INC ) 2019 second_quarter MED quality of laboratory testing Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 1 2019-07-01T09:24:11.303000-04:00
2298361 FRANCIS EDWARD & CRONIN, INC. 88a935ec-102c-404f-bd6e-2be7561288d0 Q2 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2019 second_quarter MED Issues and legislation related to Alzheimer's disease research Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 20000   0 0 2019-07-01T10:24:21.030000-04:00
2298363 FRANCIS EDWARD & CRONIN, INC. 0b04ce92-889f-47bd-99e2-1350631afc23 Q2 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2019 second_quarter MED Issues and legislation related to diabetes treatment and diagnosis Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2019-07-01T10:26:22.687000-04:00
2298541 MR. BRIAN KELLY 09ae6202-886a-46ac-b516-0ca4d33151ba Q2 MR. BRIAN KELLY 40024191 INTELLIA THERAPEUTICS 2019 second_quarter MED WHO Gene Editing Summit Defense Advanced Research Projects Agency (DARPA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office 15000   0 0 2019-07-01T17:30:36.810000-04:00
2298642 AMERICAN COLLEGE OF CLINICAL PHARMACY 654ca888-9145-4b8c-b9af-df6f5c31057f Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2019 second_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2019-07-02T10:25:36.093000-04:00
2298666 FEDERAL SOLUTIONS, LLC 96df5882-16f9-4815-a1fa-25f4ecd28d5a Q2 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2019 second_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research. Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2019-07-02T10:48:42.547000-04:00
2298772 LOCKRIDGE, GRINDAL, NAUEN, PLLP 19b77f43-dd2b-4ac6-baca-40a8f634cca1 Q2 LOCKRIDGE, GRINDAL, NAUEN, PLLP 23053 HENNEPIN COUNTY MEDICAL CENTER 2019 second_quarter MED FY2020 Authorizations, Appropriations, and Budget Policy HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-07-02T11:55:25.853000-04:00
2298893 NATURAL RESOURCE RESULTS LLC 39e82610-8b1d-4405-ab63-af50fd26c33d Q2 NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2019 second_quarter MED Support budget and approps for grants to cooperatives on medical isotope MO-99 production facility. Energy, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 10000   0 0 2019-07-02T15:18:33.500000-04:00
2298946 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 81093bec-49c1-478f-a29c-f838c6f65ccc Q2 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 401103437 AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION 2019 second_quarter MED Support Preserving Patient Access to Compounded Medications Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)     0 0 2019-07-02T16:04:54.367000-04:00
2299239 REPUBLIC CONSULTING, LLC fb931655-b239-4d2d-9578-cabb0e348eb3 Q2 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2019 second_quarter MED Monitor Data and Science policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 110000   0 0 2019-07-03T12:19:29.370000-04:00
2299244 REPUBLIC CONSULTING, LLC d267212c-dc2b-4ffe-b706-5484bfb3431f 2A REPUBLIC CONSULTING, LLC 401016871 IQVIA 2019 second_quarter MED Monitor Data and Science policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-07-03T12:31:31.197000-04:00
2299315 NEOGENOMICS LABORATORIES 3a7dbbc8-a313-4d21-bafd-19891a910489 Q2 NEOGENOMICS LABORATORIES 401105014 NEOGENOMICS LABORATORIES 2019 second_quarter MED Diagnostic Accuracy and Innovation Act Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 52615   0 0 2019-07-03T13:58:03.927000-04:00
2299424 MARSHALL BRACHMAN 4cf3c8b4-4980-4c2b-ba7e-bc5fbc05dbac Q2 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2019 second_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2019-07-03T17:22:55.903000-04:00
2299514 HOLLAND & KNIGHT LLP 84c0b68d-318c-48af-861f-8e7b3a4165e0 Q2 HOLLAND & KNIGHT LLP 18466 PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION 2019 second_quarter MED Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; House and Senate FY 2020 Ag-FDA Appropriations bills and reports (H.R. 3164); Sunscreen use in schools; Sunscreen provisions in H.R. 3443, Over-the-Counter Monograph Safety, Innovation and Reform Act of 2019; Issues related to state bans on sunscreen ingredients. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2019-07-05T10:54:07-04:00
2299711 OTT BIELITZKI & O'NEILL PLLC 3e36c854-4974-4979-b495-eeba631def86 Q2 OTT BIELITZKI & O'NEILL PLLC 401103584 BIOPORTO DIAGNOSTICS A/S 2019 second_quarter MED Educating officials about a health care diagnostic tool. Agriculture, Dept of (USDA),Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2019-07-06T06:23:02.090000-04:00
2299789 AMERICAN GASTROENTEROLOGICAL ASSOCIATION 435b7581-7091-4095-8cec-bea02281ae75 Q2 AMERICAN GASTROENTEROLOGICAL ASSOCIATION 59650 AMERICAN GASTROENTEROLOGICAL ASSOCIATION 2019 second_quarter MED Lobbied for a $2 billion increase in funding for the NIH. Also lobbied for increased funding for the VA's medical and prosthetic research program as well as increased funding for the DoD's Peer-Reviewed Cancer Research Program. HOUSE OF REPRESENTATIVES,SENATE   80000 0 0 2019-07-08T09:59:30.437000-04:00
2299845 KUTAK ROCK LLP 2098e22b-5232-4258-910f-fd546e965b7d Q2 KUTAK ROCK LLP 21962 NE ENTERPRISES 2019 second_quarter MED Reauthorization of Pandemic and All Hazards Preparedness Act and related matters   20000   0 0 2019-07-08T11:50:07.027000-04:00
2299867 O'NEILL AND ASSOCIATES b4955ceb-fe7c-48ca-bff6-c919fca3afd8 Q2 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2019 second_quarter MED Medical HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2019-07-08T12:31:21.937000-04:00
2299875 O'NEILL AND ASSOCIATES 4ab3af91-b8f1-45f4-8850-6b5a44381e52 Q2 O'NEILL AND ASSOCIATES 73134 ANALOGIC 2019 second_quarter MED Medical Technology HOUSE OF REPRESENTATIVES,SENATE 7500   0 0 2019-07-08T12:42:28.940000-04:00
2300118 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 6d55ba03-3546-4909-813a-9d2bd82a03c0 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION FOR MOLECULAR PATHOLOGY 2019 second_quarter MED Regulation of laboratory diagnostics HR 5062, Advancing Access to Precision Medicine Act No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-07-09T10:07:29.647000-04:00
2300122 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8b9b8850-3a43-4f38-9a27-5aa16c2e8d26 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ENDOCRINE SOCIETY 2019 second_quarter MED Research in Endocrinology, Standardization of Hormone Testing Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2019-07-09T10:16:31.587000-04:00
2300192 CAPITOL IMPACT, LLC f103fffe-2669-4d83-87fc-a0c9954ddd15 Q2 CAPITOL IMPACT, LLC 284471 THE LIVINGSTON GROUP, LLC (RUSH UNIVERSITY MEDICAL CENTER) 2019 second_quarter MED Congressional Letter to increase NIH funding. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-07-09T11:42:14.610000-04:00
2300524 THORN RUN PARTNERS 37bd800a-4fe3-4c13-9ae0-cd547c600c30 Q2 THORN RUN PARTNERS 400534596 GLAUKOS CORPORATION 2019 second_quarter MED Issues related to implementation of the 21st Century Cures Act (P.L.114-255). HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2019-07-09T16:43:21.893000-04:00
2300615 MICHAEL N. MCCARTY LAW OFFICE PLLC cabde6a6-c765-4ed5-8cdf-b81048642efd Q2 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2019 second_quarter MED Appropriations for harmonization of diagnostic laboratory test results; Appropriations for CDC initiative to establish pediatric reference intervals for clinical diagnostic testing; proposed legislation to establish clinical laboratory workforce development initiatives under the Public Health Service Act and other potential legislative vehicles; prospective legislation to regulate in vitro clinical diagnostic tests, including laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-07-09T19:39:10.067000-04:00
2300760 MCDERMOTT+ LLC 61fdeefa-ccb4-4aff-a1da-78c392e55372 Q2 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2019 second_quarter MED Issues concerning regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2019-07-10T10:27:44.263000-04:00
2300908 TCH GROUP, LLC c7f07ff0-b691-448d-a9a6-b4787ddc477f Q2 TCH GROUP, LLC 51478 INTERNATIONAL AIDS VACCINE INITIATIVE 2019 second_quarter MED FY 20 State Foreign Operations Subcommittee Appropriations bills (HR 2740 and HR 2839). Specifically, continued Federal funding under USAID for AIDS vaccine research and development. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-07-10T12:43:17.780000-04:00
2301197 THORN RUN PARTNERS f18371a2-7436-4c74-b640-d3a1790f7565 Q2 THORN RUN PARTNERS 400534596 BIOGEN 2019 second_quarter MED Issues dealing with newborn screening. Issues dealing with Alzheimer's treatments. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2019-07-10T17:20:06.900000-04:00
2301214 RAY C CULVER III 8b7cb98c-67de-40f7-856c-86b9b889cb03 Q2 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2019 second_quarter MED Funding for USDA ARS Human Nutrition Research Centers in FY20 Agricultural Appropriations (H.R.3055). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-07-10T18:11:19.420000-04:00
2301460 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 29da3f0b-37ae-49ac-a1f3-be14223c62d9 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2019 second_quarter MED HR 2968, Department of Defense Appropriations Act 2020 HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020 Peer-Reviewed Medical Research Program Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2019-07-11T11:53:35.437000-04:00
2301472 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 804ef0a7-76f5-4382-a152-ac69a1ad48b6 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 FOUNDATION FOR PERIPHERAL NEUROPATHY 2019 second_quarter MED HR 2968, Department of Defense Appropriations Act 2020 HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020 HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-07-11T12:04:44.017000-04:00
2301475 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 70644966-86f8-4aa9-bd5c-77908a46b6e0 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 PANCREATIC CANCER ACTION NETWORK (PANCAN) 2019 second_quarter MED cancer research at DOD and NIH HR 2968, Department of Defense Appropriations Act 2020 HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020 Peer Reviewed Medical Research HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2019-07-11T12:06:44.940000-04:00
2301477 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 0e7aa66b-61ed-44f9-b062-f5fc0ad29a5a Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION 2019 second_quarter MED Research opportunities at the Department of Defense and the Centers for Disease Control HR 2968, Department of Defense Appropriations Act 2020 HR 2740, Labor, HHS, Education, Defense, State, Foreign Operations & Energy & Water Development Appropriations Act 2020 Defense Medical Research, NIH funding HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2019-07-11T12:08:47.580000-04:00
2301520 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a20727ee-506e-4a11-9570-efe45f613793 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2019 second_quarter MED Hemophilia research, prevention, surveillance and service programs and issues Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2019-07-11T12:48:03.180000-04:00
2301832 MOLNLYCKE HEALTH CARE US, LLC 15afa9a3-fe2f-4682-8585-aebb32254d4b Q2 MOLNLYCKE HEALTH CARE US, LLC 401104898 MOLNLYCKE HEALTH CARE US, LLC 2019 second_quarter MED Pursuance of approval from relevant agencies of a medical pilot program; gathering support from Congressional leaders. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2019-07-11T16:33:08.050000-04:00
2302058 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER f839166e-2a0f-4f97-8699-73e9b3eace56 Q2 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2019 second_quarter MED NIH Budget, PCORI re authorization, NICHD budget, sickle cell research, CHGME, 340B, surprise billing legislation, screening and enrollment issues Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   39050 0 0 2019-07-12T09:53:14.490000-04:00
2302181 EFB ADVOCACY, LLC e539694c-1c53-4483-b554-f6c61f359577 Q2 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2019 second_quarter MED Funding Issues Related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-07-12T10:45:55.747000-04:00
2302223 SPECTRUM PUBLIC AFFAIRS ec4a6be9-2ab5-4dd9-b231-615fd3c955d2 2T SPECTRUM PUBLIC AFFAIRS 401103271 WESTERN MICHIGAN UNIVERSITY 2019 second_quarter MED Opioid policy and research. Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2019-07-12T11:01:16.217000-04:00
2302459 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 74a08e2b-eea9-4bc2-afc3-16e74401e9d9 Q2 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 314055 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 2019 second_quarter MED Support for Medical Research Funding Programs at the National Institutes of Health, the National Eye Institute, and the Department of Defense HOUSE OF REPRESENTATIVES,SENATE   64042 0 0 2019-07-12T14:03:57.613000-04:00
2302483 HANCE SCARBOROUGH 7c5bd5d4-6a53-46f9-b45b-3712879730d8 Q2 HANCE SCARBOROUGH 17443 TITAN PHARMACEUTICALS, INC. 2019 second_quarter MED Medicare/Medicaid drug coverage, opioid addiction policy. HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-07-12T14:12:03.647000-04:00
2303301 THE CJR GROUP, INC. 737a3f5c-8a86-4b17-b854-1a6ba09e2348 Q2 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2019 second_quarter MED NIH funding, mental health initiatives HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2019-07-15T11:29:59.117000-04:00
2303429 WAKE FOREST UNIVERSITY HEALTH SCIENCES 479234d0-538f-4c61-a9c4-5a47486c86f3 Q2 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2019 second_quarter MED Lifting of spending caps and raising the debt ceiling discussions, VA Research funding and access; VA Missions Act implementation; FY 2020 President's Budget Request for VA Research Programs; Higher Education Act reauthorization; animal research legislation; FY 2020 President's Budget Request for Departments of Labor/HHS Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2019-07-15T12:29:50.040000-04:00
2303520 ALPINE GROUP PARTNERS, LLC. 779bee4a-42bb-4f80-a5d5-780348ec4e76 Q2 ALPINE GROUP PARTNERS, LLC. 1171 ROBOKIND 2019 second_quarter MED Issues relating to autism education and research HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2019-07-15T13:16:17.123000-04:00
2303768 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. dc12826f-3363-4409-a808-47d781645549 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2019 second_quarter MED Research and public health programs in epilepsy. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2019-07-15T14:58:46.683000-04:00
2303779 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 02cfcc66-7b5e-4d09-94b7-24e94e836b00 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2019 second_quarter MED Research in hematology Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2019-07-15T15:00:50.497000-04:00
2304011 INTUITIVE SURGICAL, INC. d00fe58c-7c0d-4d71-932b-3a842c80958e Q2 INTUITIVE SURGICAL, INC. 400670004 INTUITIVE SURGICAL, INC. 2019 second_quarter MED comparative effectiveness research in healthcare Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2019-07-15T16:08:14.567000-04:00
2304051 HACKENSACK MERIDIAN HEALTH 63c22576-d49e-4d6c-bfb5-9b493f6870c8 Q2 HACKENSACK MERIDIAN HEALTH 401104109 HACKENSACK MERIDIAN HEALTH 2019 second_quarter MED National Institutes of Health funding Behavioral health Substance abuse, opioids, and patient data Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2019-07-15T16:23:32.317000-04:00
2304064 AMERICA'S BLOOD CENTERS 5ada95c3-3a4d-4aad-bdd0-12253d9420fa Q2 AMERICA'S BLOOD CENTERS 3834 AMERICA'S BLOOD CENTERS 2019 second_quarter MED Value of Blood/Reimbursement Blood center testing for Babesia Bacterial risk strategies for platelets Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2019-07-15T16:29:36.630000-04:00
2304475 MAGNET STRATEGY GROUP 9630cda2-a9eb-4cc5-85e1-a60cadd3af67 Q2 MAGNET STRATEGY GROUP 401104125 MEDICAGO INC. 2019 second_quarter MED Strategies for emergency heath response, with respect to development and deployment of medical countermeasures for emerging infectious disease. HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-07-16T09:57:07.867000-04:00
2304510 SQUIRE PATTON BOGGS 87d24faa-7a42-4738-a5ce-ce4912009b5a Q2 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2019 second_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 80000   0 0 2019-07-16T10:14:22.883000-04:00
2304526 FAEGRE DRINKER BIDDLE & REATH LLP 76c83744-e97e-4b04-aded-4fc110e3efeb Q2 FAEGRE DRINKER BIDDLE & REATH LLP 12631 DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA 2019 second_quarter MED Issues related to anti-microbial resistance and neglected tropical diseases.   10000   0 0 2019-07-16T10:15:27.477000-04:00
2304538 SQUIRE PATTON BOGGS 69393ca1-b9c7-4fdc-87eb-4dc76df9eed8 Q2 SQUIRE PATTON BOGGS 30906 IMPACT JOURNALS, LLC 2019 second_quarter MED National Library of Medicine publication and archive matters. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2019-07-16T10:20:33.680000-04:00
2304567 SQUIRE PATTON BOGGS 6e25ff4c-0436-4e68-8f92-ae3f4f9c358d Q2 SQUIRE PATTON BOGGS 30906 MOLNLYCKE HEALTH CARE US, LLC 2019 second_quarter MED Working with congressional leaders to improve pressure ulcer reimbursement and awareness and other hospital acquired conditions. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2019-07-16T10:30:45.120000-04:00
2304581 SQUIRE PATTON BOGGS cd5dbaf2-4de3-42b0-83ee-24a0be671221 Q2 SQUIRE PATTON BOGGS 30906 UNIVERSITY OF GEORGIA 2019 second_quarter MED Traumatic brain injury research, funding, and outreach opportunities. Research related to emerging and infectious diseases. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2019-07-16T10:34:48.653000-04:00
2304657 THE PETRIZZO GROUP, INC. b7670b95-5295-44bd-9f3b-c11c5c003595 Q2 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2019 second_quarter MED Advocated for funding of the BRAIN Initiative, Alzheimer's research full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2019-07-16T11:13:25.390000-04:00
2305080 ISEMAN & ASSOCIATES LLC 2a0cf943-8a71-46d1-8dcb-4e56f4f9cc37 Q2 ISEMAN & ASSOCIATES LLC 401103582 TICHENOR VENTURES, LLC 2019 second_quarter MED Monitoring biotech legislation HOUSE OF REPRESENTATIVES,SENATE 12500   0 0 2019-07-16T13:35:15.703000-04:00
2305374 AMERICAN PHYSICAL THERAPY ASSOCIATION 279845eb-32eb-40c0-9d00-1dc3624da761 Q2 AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2019 second_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding Physical Therapist role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office   243000 0 0 2019-07-16T14:36:17.020000-04:00
2305920 LNE GROUP a7d363dd-6940-4cfc-8b59-7ffa9cc36b6e Q2 LNE GROUP 308811 HOSPICE OF THE WESTERN RESERVE 2019 second_quarter MED lobbied for medical issues Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 20000   0 0 2019-07-16T17:02:22.677000-04:00
2306228 LNE GROUP 9acc4fe5-cdd8-4b49-8475-a8d19e3f22ff Q2 LNE GROUP 308811 OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE) 2019 second_quarter MED lobbied for medical issues Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-07-17T09:14:26.643000-04:00
2306287 WILLIAMS AND JENSEN, PLLC b1821fad-bbac-494f-ad5c-28012f91cd6c Q2 WILLIAMS AND JENSEN, PLLC 41454 VERTEX PHARMACEUTICALS INCORPORATED 2019 second_quarter MED General education about FDA approval policies and NIH research activities. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-07-17T10:01:47.023000-04:00
2306293 WILLIAMS AND JENSEN, PLLC 753b6ee3-c2ee-4af1-8a26-16c4a66d833a Q2 WILLIAMS AND JENSEN, PLLC 41454 SANOFI, U.S. 2019 second_quarter MED General education about FDA approval policies and NIH research activities. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-07-17T10:02:48.117000-04:00
2306461 WILLIAMS AND JENSEN, PLLC 6ece8168-9d72-43ea-b12e-81cbdfa2efbc Q2 WILLIAMS AND JENSEN, PLLC 41454 GLOBAL DOWN SYNDROME FOUNDATION 2019 second_quarter MED Support for down syndrome research funding. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 40000   0 0 2019-07-17T10:42:47.807000-04:00
2306489 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 5d48294a-6613-4e7d-b836-b92ae6a7c039 Q2 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 3435 AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 2019 second_quarter MED Affordable Care Act; Medicare; Electronic Health Records; Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Clinical Laboratory Improvement Amendments; Physician Quality Reporting System; Medicare Local Coverage Determination Reform; Medical Devices (Laboratory Tests); Stark Self-Referral Reform; Physician and Allied Health Shortages and Education; Appropriations for Federal Health Agencies; Global Health Initiative; Non-Communicable Diseases Agency for Healthcare Research & Quality (AHRQ),Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Veterans Affairs, Dept of (VA),White House Office   42000 0 0 2019-07-17T10:50:00.137000-04:00
2306528 FAEGRE DRINKER BIDDLE & REATH LLP 4229e0c2-e2ef-464b-80bf-e0aa0174da85 Q2 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2019 second_quarter MED Public Health Programs for Infectious and Tropical Disease and Anti-Microbial Resistance; NIH Research. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2019-07-17T10:57:12.623000-04:00
2306546 FAEGRE DRINKER BIDDLE & REATH LLP 8ffa59d7-8177-4363-b423-2f48115f1797 Q2 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH 2019 second_quarter MED H.R. 6378 Pandemic All Hazards Preparedness Act Reauthorization; S. 2852 Pandemic and All Hazards Preparedness and Advancing Innovation Act; H.R. 3460 End Neglected Tropical Diseases Act; COMPETES Act Reauthorization. HOUSE OF REPRESENTATIVES 20000   0 0 2019-07-17T10:58:18.343000-04:00
2306550 FAEGRE DRINKER BIDDLE & REATH LLP 59c3b571-d1f0-4bab-b0c2-f5bf5606532d Q2 FAEGRE DRINKER BIDDLE & REATH LLP 12631 PREECLAMPSIA FOUNDATION 2019 second_quarter MED Preeclampsia Research Issues. Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-07-17T11:00:20.327000-04:00
2306648 WILLIAMS AND JENSEN, PLLC f768396c-0e49-44f8-9032-52df9b2ba75c Q2 WILLIAMS AND JENSEN, PLLC 41454 MT PHARMA AMERICA, INC. 2019 second_quarter MED Matters affecting access to pharmaceuticals; payment policies for drugs under Medicare Part B; Coverage of drugs under Part B and Part D. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-07-17T11:16:10.577000-04:00
2306725 ISEMAN & ASSOCIATES LLC 1a3d521a-feea-4c5f-b5dd-9c0ac01d4ea9 Q2 ISEMAN & ASSOCIATES LLC 401103582 PILLNURSE, LLC 2019 second_quarter MED Medical device funding HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2019-07-17T11:36:42.550000-04:00
2306748 COMMONWEALTH POLICY SOLUTIONS 80eed109-3a41-4a02-b3aa-c3105f383a48 Q2 COMMONWEALTH POLICY SOLUTIONS 401105004 TRISALUS LIFE SCIENCES 2019 second_quarter MED Medical device development for oncology, drug delivery for oncology HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-07-17T11:41:50.893000-04:00
2306760 COMMONWEALTH POLICY SOLUTIONS 05b90d45-5801-4391-a98f-baf56e12d16d Q2 COMMONWEALTH POLICY SOLUTIONS 401105004 RARE ACCESS ACTION PROJECT 2019 second_quarter MED Reimbursement for rare disease patient care HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-07-17T11:43:54.330000-04:00
2306824 LNE GROUP 5e2d2535-a2f4-4b84-97f7-baaf0fef984d Q2 LNE GROUP 308811 PARKER HANNIFIN 2019 second_quarter MED lobbied on medical issues HOUSE OF REPRESENTATIVES,SENATE,U.S. Coast Guard (USCG) 80000   0 0 2019-07-17T11:50:10.317000-04:00
2306862 WASHINGTON UNIVERSITY IN ST. LOUIS 3ac67a5b-294e-48ba-8929-392e6fe9f0cf Q2 WASHINGTON UNIVERSITY IN ST. LOUIS 40031264 WASHINGTON UNIVERSITY IN ST LOUIS 2019 second_quarter MED General advocacy for NIH and other biomedical research. General support for the development of fair and effective organ transplant policies. General advocacy supporting the continued responsible utilization of research animals. HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2019-07-17T11:55:17.257000-04:00
2307061 CARDINAL HEALTH, INC. 843aaec7-5825-4a29-a79e-853a205dce43 Q2 CARDINAL HEALTH, INC. 58055 CARDINAL HEALTH INC 2019 second_quarter MED Medical Device Tax Repeal - H.R. 2207, S. 692, Protect Medical Innovation Act of 2019 Federal Emergency Management Agency (FEMA),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE   550000 0 0 2019-07-17T12:35:10.180000-04:00
2307136 THE CORMAC GROUP, LLC a5f8dadb-ecd8-4452-8f8b-86d3d9829ced Q2 THE CORMAC GROUP, LLC 66773 KESSLER FOUNDATION 2019 second_quarter MED Appropriations, DOD, TBI research, Veterans Issues Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-07-17T13:01:35.890000-04:00
2307232 THE CORMAC GROUP, LLC bb3b55ee-dd2b-4fe1-93e9-590695bb7221 Q2 THE CORMAC GROUP, LLC 66773 HEARTFLOW, INC. 2019 second_quarter MED Medicare payment issues Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-07-17T13:21:11.113000-04:00
2307455 WILLIAMS AND JENSEN, PLLC 21d2bd5d-d296-4cf0-8c16-c1d5f6dd8f01 Q2 WILLIAMS AND JENSEN, PLLC 41454 ECRI INSTITUTE 2019 second_quarter MED General education regarding patient safety initiatives, medical product safety, and evidence-based healthcare information to improve patient care. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2019-07-17T14:04:46.587000-04:00
2307723 UNIVERSITY OF IOWA 70660f97-568d-4ebd-bc39-ec7ec2c45a5b Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2019 second_quarter MED Support for all federal agencies that fund medical and disease research Commerce, Dept of (DOC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2019-07-17T14:46:24.017000-04:00
2308074 GOLDBUG STRATEGIES LLC 5673158c-6748-43a6-9d14-30d6e97af200 Q2 GOLDBUG STRATEGIES LLC 400701094 COALITION FOR 21ST CENTURY MEDICINE 2019 second_quarter MED in vitro diagnostics, clinical laboratories, digital health regulation Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-07-17T15:52:24.810000-04:00
2308096 GOLDBUG STRATEGIES LLC f8d01280-2447-4da5-acea-013b7c6533d7 Q2 GOLDBUG STRATEGIES LLC 400701094 LIFE TECHNOLOGIES/THERMO FISHER 2019 second_quarter MED in vitro diagnostics, clinical laboratories, digital health regulation Food & Drug Administration (FDA)     0 0 2019-07-17T15:57:34.777000-04:00
2308103 GOLDBUG STRATEGIES LLC 60522853-3198-49ae-869a-c20e76040d85 Q2 GOLDBUG STRATEGIES LLC 400701094 23ANDME, INC. 2019 second_quarter MED in vitro diagnostics, clinical laboratories, digital health regulation Food & Drug Administration (FDA) 10000   0 0 2019-07-17T15:58:37.560000-04:00
2308395 BALCH & BINGHAM, LLP 73871046-3623-437c-af22-94df4242dd84 Q2 BALCH & BINGHAM, LLP 5197 TRANSCENDENCE, INC. 2019 second_quarter MED New medical innovations for improved treatment.       0 0 2019-07-17T17:03:26.177000-04:00
2308665 ATLAS ADVOCACY 901bc754-70e1-420d-a0c3-577dac390b1c Q2 ATLAS ADVOCACY 401100069 BLADDER CANCER ADVOCACY NETWORK 2019 second_quarter MED CDMRP; Disease Awreness resolution HOUSE OF REPRESENTATIVES,SENATE 9000   0 0 2019-07-17T21:00:52.133000-04:00
2308670 GOVERNMENT COUNSEL, LLC e2f58525-7475-473d-b7ef-d8da638e61f4 Q2 GOVERNMENT COUNSEL, LLC 401105070 HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) 2019 second_quarter MED The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018 HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-07-17T21:14:53.887000-04:00
2308867 GREENBERG TRAURIG, LLP d47f504e-96d7-45cb-9a3d-83c4d318d301 Q2 GREENBERG TRAURIG, LLP 16896 AMERICAN SOCIETY INTERVENTIONAL PAIN PHYSICIANS 2019 second_quarter MED Outreach and monitoring related to the implementation of the Patient Protection and Affordable Care Act (P.L. 111-148). Outreach and monitoring related to federal and legislative activity related to health care and reauthorization of National All Schedules Prescription Electronic Reporting Act (NASPER) (P.L. 109-60). Outreach and monitoring related to federal and legislative activity related to Medicare Reimbursement. Outreach and monitoring related to federal issues and legislation associated with health care policy. Outreach and monitoring related to federal issues and legislation associated with opioids. H.R. 3107 Improving Seniors Timely Access to Care Act of 2019 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-07-18T09:35:11.967000-04:00
2309075 UNIVERSITY OF MIAMI f85e92c8-cf43-4335-8aaf-83f970144e39 Q2 UNIVERSITY OF MIAMI 39462 UNIVERSITY OF MIAMI 2019 second_quarter MED Fire Fighter Cancer Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE   62000 0 0 2019-07-18T10:12:33.847000-04:00
2309101 THORN RUN PARTNERS bbc5a69d-b9dc-4833-9651-6a0fdd70a32b Q2 THORN RUN PARTNERS 400534596 CONTINUING MEDICAL EDUCATION COALITION 2019 second_quarter MED Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS; Expressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and prescribing opioids, and for other purposes (H.Con.Res.8). Policies to promote the use of continuing medical education to support greater physician understanding about biosimilars. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2019-07-18T10:16:40.910000-04:00
2309459 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) a081aaf1-830c-49b0-bf4f-6f58b19db2ae Q2 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 COLOR HEALTH (FKA COLOR GENOMICS) 2019 second_quarter MED Lobbying related to healthcare issues. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-07-18T11:07:50.417000-04:00
2309554 BIODESIX 49243b3a-c5dd-447e-a145-9ed45a579c38 Q2 BIODESIX 401105286 BIODESIX 2019 second_quarter MED -Regulation of laboratory developed tests (Verifying Accurate, Leading-edge IVCT Development (VALID) Act discussion draft) Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   58000 0 0 2019-07-18T11:22:27.557000-04:00
2309628 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 5998680a-462b-49d7-8ce5-0a009c2e2c95 Q2 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 INTUITIVE SURGICAL, INC. 2019 second_quarter MED Lobbying related to health care issues. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-07-18T11:34:51.507000-04:00
2309751 BALLARD PARTNERS 5c16994e-5584-41a7-926f-19d533c8a504 Q2 BALLARD PARTNERS 401104288 LABORATORY CORPORATIONS OF AMERICA HOLDINGS 2019 second_quarter MED Clinical Lab Rates Health & Human Services, Dept of (HHS),White House Office 80000   0 0 2019-07-18T12:13:44.560000-04:00
2309827 THE PETRIZZO GROUP, INC. a3f00942-5355-474d-a9c4-24631e0759ad Q2 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2019 second_quarter MED Advocated for Medicare Part B packaged payment reforms; and the expansion of the non-opioid pain management drug exclusion to the drugs functioning as supplies during a surgical procedure packaging policy. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE,Vice President of the U.S.,White House Office 75000   0 0 2019-07-18T12:31:16.733000-04:00
2309916 THE PETRIZZO GROUP, INC. be028e35-838b-4a85-a0b4-76ac19e44d50 Q2 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2019 second_quarter MED Funding for NIH research; increased funding for sickle cell research HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2019-07-18T12:56:47.627000-04:00
2309932 THE PETRIZZO GROUP, INC. 44703dfb-a457-4fe7-ab57-2b0b53eb6606 Q2 THE PETRIZZO GROUP, INC. 305932 UNITED BIOMEDICAL, INC. 2019 second_quarter MED Advocated for federal funding and development of robust vaccine research for Alzheimer's, Parkinson's and other neurological diseases. Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),SENATE,White House Office 50000   0 0 2019-07-18T13:01:53.767000-04:00
2309991 MGD STRATEGIES LLC e5af20f3-93a3-4a2a-8e4e-cbc5acf03ed2 2T MGD STRATEGIES LLC 401104776 ESOPHAGEAL CANCER ACTION NETWORK (ECAN) 2019 second_quarter MED Report language in the Department of Defense Appropriations bills to include esophageal cancer in the Peer-Reviewed Cancer Research Program HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2019-07-18T13:11:16.800000-04:00
2310106 DLA PIPER LLP (US) e6de9598-be20-430f-8735-bfab296259b4 Q2 DLA PIPER LLP (US) 76855 PATIENT POCKET LLC 2019 second_quarter MED Issues related to operating room safety policies. H.R. 2745, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2020. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-07-18T13:39:01.663000-04:00
2310207 SQUIRE PATTON BOGGS 3ebd0522-88b2-42d6-b247-d9670c58c7fc Q2 SQUIRE PATTON BOGGS 30906 THOMAS JEFFERSON UNIVERSITY 2019 second_quarter MED Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-07-18T14:02:36.010000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2197.228ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API